iXensor
Taipei · Founded 2012
About iXensor
iXensor is the global pioneer of mobile health. We turn ordinary smartphones into versatile lab-grade medical diagnostic devices for point-of-care testing and at-home self-testing solutions. PixoTest®, our first product, is also the world's first FDA approved smartphone camera-based blood test dated back in 2017. Founded at Stanford University, Palo Alto, and incorporated in Taipei, Taiwan, in 2012, our international team combines expertise in medical engineering, biochemistry, and information technology to develop innovative health-tech products and digital health solutions that empower the connected healthcare of tomorrow. Our product lines cover Women’s Health, Chronic, and Infectious Diseases are all powered by our core technology - PixoTech® platform. It serves as our engine for the next phase of growth. We have received many international awards for our innovation, and our business has also been accelerated by Merck Accelerator, Plug & Play’s Creasphere, and Johnson & Johnson Innovation’s JLABs.
Company Facts
- Founded: 2012
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $21.8M
- Last round: Corporate Round (Apr 2022)
- Website: https://www.ixensor.com/ixensor_web
- Phone: +886287511335
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Home Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/ixensor-40322 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.